Patient recruitment was slow; the aim was 40 patients in the first phase, which would be winnowed down to 20 for a second visit to NIH a year after the first. I'm not sure why recruitment was so slow. There was skepticism in the patient community due to NIH's longtime neglect and dismissal of the illness. 7/